Phase I study of tilorone, a non-marrow depressing antitumor agent.

Phase I study of tilorone, a non-marrow depressing antitumor agent. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Phase I study of tilorone, a non-marrow depressing antitumor agent. Abstract Text:

G L Wampler,M Kuperminc,W Regelson,

Phase I study of tilorone, a non-marrow depressing antitumor agent. Publishing Authors By Initials

GL Wampler,M Kuperminc,W Regelson,

For similar proteins research abstracts see: proteins research

PUBMED ID PMID:

MEDLINE DATE:

Phase I study of tilorone, a non-marrow depressing antitumor agent. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 57

Page Numbers: 209-17

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Apr

YEAR: 1973

Phase I study of tilorone, a non-marrow depressing antitumor agent. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Phase I study of tilorone, a non-marrow depressing antitumor agent. Keywords Mesh Terms:

KEYWORDS: Proteins

MESH TERMS: metabolism

Chemical & Substance for Abstract: Phase I study of tilorone, a non-marrow depressing antitumor agent. Information

Substance Name: Proteins

Registry Number: 0

Grant and Affiliation Information for Phase I study of tilorone, a non-marrow depressing antitumor agent.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Phase I study of tilorone, a non-marrow depressing antitumor agent Related Publications

• Anionic polymers. III. The tissue distribution and metabolism of polyxenylphosphate in tumor-bearing mice.
• Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
• Phase I study of tilorone, a non-marrow depressing antitumor agent.